RXST RxSight, Inc.
Healthcare$6.01+0.00%OpenMarket Cap: $248.6M
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$10.25
Target (Median)
$10.50
Target Range
$9.00 - $11.00
Upside from current price: 70.7%
Rating Distribution
1 Strong Buy0 Buy6 Hold0 Sell2 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-07 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| 2026-05-07 | Needham | maintain | Buy | Buy |
| 2026-03-09 | Stifel | maintain | Hold | Hold |
| 2026-02-26 | Needham | maintain | Buy | Buy |
| 2026-02-26 | Piper Sandler | maintain | Neutral | Neutral |
| 2026-02-26 | UBS | maintain | Neutral | Neutral |
| 2026-01-20 | Piper Sandler | maintain | Neutral | Neutral |
| 2025-12-02 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| 2025-11-06 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| 2025-11-06 | JP Morgan | maintain | Underweight | Underweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Wed Dec 31 | $-1.05 | $131.6M | 3 |
| Thu Dec 31 | $-1.42 | $129.2M | 5 |
| Fri Dec 31 | $-1.28 | $142.3M | 5 |
| Sun Dec 31 | $-1.19 | $155.0M | 5 |